ID: ALA4071281

Max Phase: Preclinical

Molecular Formula: C11H8N2O

Molecular Weight: 184.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1cc(-c2ccccc2)oc1N

Standard InChI:  InChI=1S/C11H8N2O/c12-7-9-6-10(14-11(9)13)8-4-2-1-3-5-8/h1-6H,13H2

Standard InChI Key:  UWTDTJWGYWUILP-UHFFFAOYSA-N

Associated Targets(Human)

Ubiquitin-conjugating enzyme E2 T 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 184.20Molecular Weight (Monoisotopic): 184.0637AlogP: 2.40#Rotatable Bonds: 1
Polar Surface Area: 62.95Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.80CX LogD: 1.80
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.74Np Likeness Score: -0.57

References

1. Morreale FE, Bortoluzzi A, Chaugule VK, Arkinson C, Walden H, Ciulli A..  (2017)  Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening.,  60  (9): [PMID:28437106] [10.1021/acs.jmedchem.7b00147]

Source